Semler Scientific, Inc. (NASDAQ:SMLR) Sees Large Growth in Short Interest

Semler Scientific, Inc. (NASDAQ:SMLR) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,280,000 shares, an increase of 43.4% from the November 15th total of 892,400 shares. Based on an average daily trading volume, of 485,000 shares, the days-to-cover ratio is currently 2.6 days. Currently, 20.4% of the company’s shares are short sold.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Principal Financial Group Inc. bought a new stake in Semler Scientific in the third quarter valued at $361,000. Shariaportfolio Inc. bought a new position in shares of Semler Scientific during the third quarter valued at $3,618,000. CWM LLC boosted its holdings in Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the last quarter. Verition Fund Management LLC bought a new stake in shares of Semler Scientific during the 3rd quarter valued at about $251,000. Finally, Cerity Partners LLC raised its position in Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after acquiring an additional 642,982 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Stock Down 6.5 %

SMLR stock traded down $4.67 during midday trading on Friday, reaching $67.17. 971,401 shares of the company’s stock traded hands, compared to its average volume of 1,077,116. The firm’s fifty day moving average price is $43.82 and its 200-day moving average price is $34.79. The company has a market cap of $556.84 million, a price-to-earnings ratio of 32.77 and a beta of 1.18. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $79.45.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million during the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.